Pharma

	27/4 09:13 af ProInvestorNEWS	Orbital bags $270 million to advance RNA-based therapeutics (link)
	27/4 09:13 af ProInvestorNEWS	FDA staff flag concerns over broad use of Lynparza combo in prostate cancer FDA staff flag concerns over broad use of Lynparza combo in prostate cancer
	27/4 09:02 af ProInvestorNEWS	GSK's Respiratory Syncytial Virus Older Adult Vaccine Candidate Gets Positive CHMP Opinion (link)
	27/4 09:01 af ProInvestorNEWS	AstraZeneca Q1 Core Profit Rises, Revenue Ex COVID-19 Up 15% At CER; Reiterates FY23 Guidance (link)
	27/4 06:38 af ProInvestorNEWS	Nordea hæver kursmålet på Lundbeck We raise our revenue estimates by 1-2% going forward, EBITDA estimates by 2% and EBIT estimates by 3-4% – driven by Rexulti and slightly better operating leverage. Our DCF-derived target price is raised to DKK 44 (41) and we remain buyers of the stock
	27/4 05:31 af ProInvestorNEWS	Novo-topchef ser EU-forslag som "det dummeste jeg har hørt" (link)
	27/4 05:30 af ProInvestorNEWS	Medicinalsektor kritiserer EU-forslag om revision af regulering (link)
	26/4 05:20 af ProInvestorNEWS	FDA Grants Accelerated Approval For Biogen's ALS Drug (link)
	25/4 08:28 af ProInvestorNEWS	Pfizer bags FDA approval for Zavzpret migraine nasal spray (link)
	25/4 08:16 af ProInvestorNEWS	Mere migræne : IntelGenx Announces FDA Approval of RIZAFILM for the Treatment of Acute Migraine (link)
	25/4 08:15 af ProInvestorNEWS	(Lundbeck er på vej i samme indikation)
	25/4 08:14 af ProInvestorNEWS	FDA expands approval of AbbVie's Qulipta to chronic migraine (link)
	25/4 08:05 af ProInvestorNEWS	AstraZeneca, Ionis' eplontersen shows sustained benefit on neuropathy impairment, QoL (link)
	25/4 06:08 af ProInvestorNEWS	Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance 25.4.2023 07.00 • GlobeNewswire • Ad hoc announcement pursuant to Art. 53 LR Q1 sales grew +8% (cc 1 , +3% USD) and core operating income grew +15% (cc, +8% USD) * Innovative Medicines (IM) sales grew +7% (cc, +3% USD) and core operating income +18% (cc, +11% USD) * IM core margin 38.7%, +360 bps cc, driven by higher sales and productivity programs
	23/4 13:15 af ProInvestorNEWS	Is Teladoc Health a Good Stock to Buy Now? (link)
	23/4 13:14 af ProInvestorNEWS	Is Abbott Laboratories Still a Good Dividend Stock to Buy? (link)
	21/4 06:00 af ProInvestorNEWS	Lundbeck får hævet kursmålet hos britisk storbank (link)
	20/4 06:14 af ProInvestorNEWS	Har Alk-Abello fået (u)berettiget mange kursklø? (link)
	20/4 05:57 af ProInvestorNEWS	Forskningsdirektør: Lundbeck tættere på middel mod migræne (link)
	19/4 15:49 af ProInvestorNEWS	Sydbank kalder Lundbecks migrænemiddel for spændende i stort migrænemarked (link)
	19/4 15:26 af ProInvestorNEWS	Lundbeck når primære endepunkt i migræneforsøg i Hope-studie (link)
	19/4 07:40 af ProInvestorNEWS	FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines (link)
	19/4 05:57 af ProInvestorNEWS	ALK-Abelló/SEB: Kursmål sænkes til 130 kr. fra 140 kr. (link)
	18/4 14:09 af ProInvestorNEWS	Norsk storbank mener nedjusteret prognose hos ALK skaber usikkerhed (link)

	18/4 11:48 af ProInvestorNEWS	Johnson & Johnson opjusterer forventningerne til 2023 (link)
	18/4 09:55 af ProInvestorNEWS	Danske Bank skærer anfaling og kursmål for ALK: Tal svagere end ventet (link)
	18/4 08:35 af ProInvestorNEWS	AbbVie's Rinvoq nabs EU approval in Crohn's disease (link)
	18/4 08:29 af ProInvestorNEWS	Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques (link)
	18/4 08:21 af ProInvestorNEWS	Pyramid Bio bets on GeneQuantum's ADC candidate for over $1 billion (link)
	18/4 08:20 af ProInvestorNEWS	FDA panel backs approval of Rexulti for Alzheimer's-related agitation (link)
	18/4 08:19 af ProInvestorNEWS	Teva, Alvotech's Humira biosimilar hit with second FDA rejection (link)
	18/4 08:02 af ProInvestorNEWS	FDA Approves Omisirge Cell Therapy For Blood Cancers (link)
	18/4 08:01 af ProInvestorNEWS	Basilea Provides Updated Timeline For NDA Submission For Antibiotic Ceftobiprole To FDA (link)
	18/4 08:00 af ProInvestorNEWS	Stimen af opkøb fortsætter: GSK To Buy BELLUS Health In US$2.0 Bln Deal (link)
	18/4 06:15 af ProInvestorNEWS	Wells Fargo Initiates Coverage of Viridian Therapeutics (VRDN) with Overweight Recommendation (link)
	18/4 06:14 af ProInvestorNEWS	HC Wainwright & Co. Reiterates Axsome Therapeutics (AXSM) Buy Recommendation(link)
	18/4 05:53 af ProInvestorNEWS	Dråbesalg styrker ALK-Abelló på toplinje og drift i første kvartal (link)
	17/4 14:26 af ProInvestorNEWS	Is Johnson & Johnson a Buy After Its Proposed $8.9 Billion Talc Settlement? (link)
	17/4 14:24 af ProInvestorNEWS	Inovio Presents Data From Phase 1b Trial With INO-4201 As Ebola Booster For RVSV-ZEBOV (link)
	17/4 07:42 af ProInvestorNEWS	GSK Plc: Gepotidacin Shows Non-inferiority To Nitrofurantoin In EAGLE-2 And EAGLE-3 Phase III Trials (link)
	17/4 06:30 af ProInvestorNEWS	Lundbeck har milliardsællert inden for rækkevidde, vurderer børshus (link)
	17/4 06:27 af ProInvestorNEWS	MorphoSys : Long-term Data Show Prolonged, Durable Responses In DLBCL Patients Treated With Monjuvi (link)
	17/4 06:27 af ProInvestorNEWS	AZN : IMFINZI-based Treatment Reduces Risk Of Disease Recurrence In Lung Cancer In Phase III Trial (link)
	17/4 06:26 af ProInvestorNEWS	Genentech : Tecentriq Combination Reduces Risk Of Cancer Returning In People With Liver Cancer (link)
	17/4 06:26 af ProInvestorNEWS	Satsuma Pharma Agrees To Be Acquired By Shin Nippon Biomedical (link)
	17/4 06:18 af LP90	Godmorgen :-)
	17/4 05:52 af ProInvestorNEWS	Internationale aviser med Merck, GM og Lloyd's of London (link)
	17/4 05:37 af ProInvestorNEWS	Lundbeck: Giver FDA panels-ja et kursboost? (link)
	16/4 15:42 af ProInvestorNEWS	+75% i præmie.
	16/4 15:40 af ProInvestorNEWS	Merck & Co. agrees to buy Prometheus for $10.8 billion (link)